Literature DB >> 8183920

Calorie restriction prevents the occlusive coronary vascular disease of autoimmune (NZW x BXSB)F1 mice.

H Mizutani1, R W Engelman, K Kinjoh, Y Kurata, S Ikehara, Y Matsuzawa, R A Good.   

Abstract

Male (NZW x BXSB)F1 (W/BF1) mice develop systemic autoimmunity involving autoantibodies, thrombocytopenia, lupus nephritis, and coronary vascular disease (CVD) with myocardial infarction. To determine whether this murine lupus-associated CVD can be prevented by the reduction of dietary calories, male W/BF1 mice were separated into five experimental groups and fed either ad libitum (designated group A, n = 50), fed 32% fewer calories of an otherwise comparable diet (designated group B6, n = 20), or initially fed ad libitum and then switched to reduced calorie intake (RCI) feeding at ages 14, 17, or 22 weeks (designated B14, n = 10; B17, n = 20; or B22, n = 20). Occlusive CVD was prevented by RCI. Life-span was significantly extended among the early onset RCI cohorts, B6 and B14 (P = 0.0001 and P = 0.005), compared to group A mice. Mean anti-cardiolipin autoantibody titers and mean levels of circulating immune complexes were also lowered in RCI mice when all RCI mice were compared to ad libitum fed group A mice. Histological grades of both coronary vascular and glomerular lesions were significantly less than those of group A mice (P < 0.001). Immunoprecipitates indicative of immunoglobulin deposition within coronary or glomerular vascular walls were also substantially less than those of group A mice. These findings indicate a possible causal role for anti-cardiolipin autoantibody in development of autoimmune CVD in W/BF1 mice and suggest that regulating dietary calories can influence the mechanism involved in pathogenesis of autoimmune-associated CVD development.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8183920      PMCID: PMC43793          DOI: 10.1073/pnas.91.10.4402

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Detection and partial characterization of circulating immune complexes with solid-phase anti-C3.

Authors:  A B Pereira; A N Theofilopoulos; F J Dixon
Journal:  J Immunol       Date:  1980-08       Impact factor: 5.422

2.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.

Authors:  S M Hsu; L Raine; H Fanger
Journal:  J Histochem Cytochem       Date:  1981-04       Impact factor: 2.479

Review 3.  Lupus anticoagulants.

Authors:  S S Shapiro; P Thiagarajan
Journal:  Prog Hemost Thromb       Date:  1982

4.  Reduction of circulating immune complexes by calorie restriction in (NZB x NZW) F1 mice.

Authors:  S Safai-Kutti; G Fernandes; Y Wang; B Safai; R A Good; N K Day
Journal:  Clin Immunol Immunopathol       Date:  1980-03

5.  Effect of fasting and lactovegetarian diet on rheumatoid arthritis.

Authors:  L Sköldstam; L Larsson; F D Lindström
Journal:  Scand J Rheumatol       Date:  1979       Impact factor: 3.641

6.  Immunopathology of cardiac lesions in fatal systemic lupus erythematosus.

Authors:  A K Bidani; J L Roberts; M M Schwartz; E J Lewis
Journal:  Am J Med       Date:  1980-12       Impact factor: 4.965

7.  Analysis of vascular lesions in murine SLE. I. Association with serologic abnormalities.

Authors:  J H Berden; L Hang; P J McConahey; F J Dixon
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

8.  Coronary arterial disease in systemic lupus erythematosus; quantification of degrees of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years.

Authors:  Y S Haider; W C Roberts
Journal:  Am J Med       Date:  1981-04       Impact factor: 4.965

9.  Monoclonal immunoglobulin M lambda coagulation inhibitor with phospholipid specificity. Mechanism of a lupus anticoagulant.

Authors:  P Thiagarajan; S S Shapiro; L De Marco
Journal:  J Clin Invest       Date:  1980-09       Impact factor: 14.808

10.  (NZW x BXSB)F1 hybrid. A model of acute lupus and coronary vascular disease with myocardial infarction.

Authors:  L M Hang; S Izui; F J Dixon
Journal:  J Exp Med       Date:  1981-07-01       Impact factor: 14.307

View more
  6 in total

Review 1.  Diet, microbiota and autoimmune diseases.

Authors:  S M Vieira; O E Pagovich; M A Kriegel
Journal:  Lupus       Date:  2014-05       Impact factor: 2.911

2.  Gut microbiota dysbiosis and altered tryptophan catabolism contribute to autoimmunity in lupus-susceptible mice.

Authors:  Seung-Chul Choi; Josephine Brown; Minghao Gong; Yong Ge; Mojgan Zadeh; Wei Li; Byron P Croker; George Michailidis; Timothy J Garrett; Mansour Mohamadzadeh; Laurence Morel
Journal:  Sci Transl Med       Date:  2020-07-08       Impact factor: 17.956

Review 3.  The role of the gut microbiota in the pathogenesis of antiphospholipid syndrome.

Authors:  William E Ruff; Silvio M Vieira; Martin A Kriegel
Journal:  Curr Rheumatol Rep       Date:  2015-01       Impact factor: 4.592

Review 4.  The Intersection of Cellular and Systemic Metabolism: Metabolic Syndrome in Systemic Lupus Erythematosus.

Authors:  Morgan Terrell; Laurence Morel
Journal:  Endocrinology       Date:  2022-07-01       Impact factor: 5.051

Review 5.  Environmental Triggers of Autoreactive Responses: Induction of Antiphospholipid Antibody Formation.

Authors:  Anush Martirosyan; Rustam Aminov; Gayane Manukyan
Journal:  Front Immunol       Date:  2019-07-10       Impact factor: 7.561

Review 6.  Diet and Hygiene in Modulating Autoimmunity During the Pandemic Era.

Authors:  Leila Abdelhamid; Xin M Luo
Journal:  Front Immunol       Date:  2022-01-05       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.